99 related articles for article (PubMed ID: 26752029)
1. [Community-based screening: a motivating experience for drug users].
Grammatico-Guillon L; Arnault É; Rollier S; Bonnemaison G; Dubois F; Rusch E
Sante Publique; 2015; 27(5):633-9. PubMed ID: 26752029
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
Loebstein R; Mahagna R; Maor Y; Kurnik D; Elbaz E; Halkin H; Olchovsky D; Ezra D; Almog S
Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
[TBL] [Abstract][Full Text] [Related]
3. Vietnamese community screening for hepatitis B virus and hepatitis C virus.
Kallman JB; Tran S; Arsalla A; Haddad D; Stepanova M; Fang Y; Wrobel VJ; Srishord M; Younossi ZM
J Viral Hepat; 2011 Jan; 18(1):70-6. PubMed ID: 20196807
[TBL] [Abstract][Full Text] [Related]
4. Is there a need to include HIV, HBV and HCV viruses in the Saudi premarital screening program on the basis of their prevalence and transmission risk factors?
Alswaidi FM; O'Brien SJ
J Epidemiol Community Health; 2010 Nov; 64(11):989-97. PubMed ID: 19822552
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004.
Larsen C; Pialoux G; Salmon D; Antona D; Le Strat Y; Piroth L; Pol S; Rosenthal E; Neau D; Semaille C; Delarocque Astagneau E
Euro Surveill; 2008 May; 13(22):. PubMed ID: 18761958
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infections among drug addicts in Bangladesh.
Shirin T; Ahmed T; Iqbal A; Islam M; Islam MN
J Health Popul Nutr; 2000 Dec; 18(3):145-50. PubMed ID: 11262767
[TBL] [Abstract][Full Text] [Related]
7. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
8. 2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Bottero J; Brouard C; Roudot-Thoraval F; Deuffic-Burban S; Hofliger P; Abergel A; Volant J; Dhumeaux D; Yazdanpanah Y;
Liver Int; 2016 Oct; 36(10):1442-9. PubMed ID: 27043826
[TBL] [Abstract][Full Text] [Related]
9. Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: screening performance and outcome.
Bolther M; Dalgaard LS; Kristensen LH; Tarp BD; Jensen-Fangel S
Scand J Infect Dis; 2014 Oct; 46(10):686-92. PubMed ID: 25134654
[TBL] [Abstract][Full Text] [Related]
10. [Prevalence of hepatitis B, hepatitis C and HIV among injecting drug users treated outpatiently and in therapeutic community in Brod-Posavina County, Croatia].
Kolovrat A; Jurisić I; Marić Z; Cvitković A
Acta Med Croatica; 2010 Oct; 64(4):287-96. PubMed ID: 21688612
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and associated clinical characteristics of hepatitis B, C, and HIV infections among injecting drug users in Korea.
Min JA; Yoon Y; Lee HJ; Choi J; Kwon M; Kim K; Lee CU; Kim DJ; Yun H
J Med Virol; 2013 Apr; 85(4):575-82. PubMed ID: 23364858
[TBL] [Abstract][Full Text] [Related]
12. Molecular epidemiology of HIV, HBV, HCV, and HTLV-1/2 in drug abuser inmates in central Javan prisons, Indonesia.
Prasetyo AA; Dirgahayu P; Sari Y; Hudiyono H; Kageyama S
J Infect Dev Ctries; 2013 Jun; 7(6):453-67. PubMed ID: 23771289
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.
Nyirenda M; Beadsworth MB; Stephany P; Hart CA; Hart IJ; Munthali C; Beeching NJ; Zijlstra EE
J Infect; 2008 Jul; 57(1):72-7. PubMed ID: 18555534
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus and hepatitis C virus infection among HIV-1-infected injection drug users in Dali, China: prevalence and infection status in a cross-sectional study.
Dong Y; Qiu C; Xia X; Wang J; Zhang H; Zhang X; Xu J
Arch Virol; 2015 Apr; 160(4):929-36. PubMed ID: 25616842
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C infection at a large public sector hospital clinic: is it a burden?
Kurira P; Ndhlovu CE; Gomo ZA
Cent Afr J Med; 2014; 60(9-12):56-62. PubMed ID: 26867256
[TBL] [Abstract][Full Text] [Related]
16. Infection with hepatitis B and C viruses and human retroviruses (HTLV-I and HIV) among high-risk Lebanese patients.
Ramia S; Klayme S; Naman R
Ann Trop Med Parasitol; 2003 Mar; 97(2):187-92. PubMed ID: 12803874
[TBL] [Abstract][Full Text] [Related]
17. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
Cullen W; Stanley J; Langton D; Kelly Y; Bury G
Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
[TBL] [Abstract][Full Text] [Related]
18. Targeted hepatitis C screening among ex-injection drug users in the community.
Wong VW; Wong GL; Chim AM; Cheng TF; Cheung SW; Lai CM; Szeto KJ; Tsang S; Wu SH; Yan KK; Hui AY; Yiu DC; Wu BB; Cheung D; Chung CS; Lai CW; Chan HL
J Gastroenterol Hepatol; 2014 Jan; 29(1):116-20. PubMed ID: 24033786
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
20. Population-based prevalence of hepatitis B and C virus, HIV, syphilis, gonorrhoea and chlamydia in male injection drug users in Lagos, Nigeria.
Tun W; Vu L; Adebajo SB; Abiodun L; Sheehy M; Karlyn A; Njab J; Ahonsi B; Issa BK; Idogho O
Int J STD AIDS; 2013 Aug; 24(8):619-25. PubMed ID: 23970571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
